More than 4w ago
…
compensation:
$100K — $150K *
industry:
specialty:
System & Network Administration, Quality Assurance
experience:
5 - 7 years
Job Description
Job Description
Qualifications
Additional Information
The Automation Engineer III will maintain and troubleshoot all process control system hardware and software (DeltaV DCS, Rockwell PLC) in support of the Development and Production scale biopharmaceutical processes.
See More - Provides software and hardware support for the Automation systems in the Technical Development and FVM areas, systems include DeltaV, Finesse reactors, Rockwell PLCs, GE Unicorn, OSI PI data historian
- Identifies projects to support continuous improvement of Automation systems supporting both Technical Development and Manufacturing areas
- Maintains training, develops goals and tracks progress
- Leads and manages small to medium engineering projects with little direction.
- Participate in multi-function teams to implement change and improve on existing processes
Qualifications
- Bachelor's degree in an Engineering discipline or Computer Sciences with at least 6 years of related experience
- Biotechnology or batch pharmaceutical experience production experience preferred
- Experience in Biotechnology Manufacturing specific areas: Cell Culture, Chromatography, Centrifugation, CIP\SIP preferred
- Fluent with various other Automation systems including (DAS), Finesse Single Use Bioreactors, GE Unicorn, OSI PI data historian.
- Working knowledge of DeltaV distributed control system
- Experience with PLCs, Finesse Reactors, OSI PI data historian
- Extensive knowledge of cGMP and GAMP guidelines
Additional Information
The Automation Engineer III will maintain and troubleshoot all process control system hardware and software (DeltaV DCS, Rockwell PLC) in support of the Development and Production scale biopharmaceutical processes.
Valid through: 1/18/2021
About Biogen
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. The company is also known for its 2020 conference being responsible for between 205,000 and 300,000 cases of coronavirus worldwide during the COVID-19 pandemic.
'%3E %3Cpath stroke='%236EA7E7' stroke-linecap='round' stroke-linejoin='round' d='M11.156 16.891C3.743 20.036.036 22.357.036 23.854v6.63h15.567'/%3E %3Cpath stroke='%236EA7E7' stroke-linecap='round' d='M19.041 18.217l-2.72-1.326'/%3E %3Cpath stroke='%2309AEBC' d='M13.52.032a5.52 5.52 0 0 1 5.525 5.527c0 1.528-.645 3.834-1.687 5.699-1.042 1.865-2.457 3.228-3.839 3.228-1.382 0-2.797-1.363-3.84-3.228-1.041-1.865-1.686-4.17-1.686-5.7A5.52 5.52 0 0 1 13.519.033z'/%3E %3Cpath stroke='%23666' stroke-linejoin='round' d='M13.139 16.916c.194.04 1.005.04 1.2 0l1.851 8.47-2.451 2.273-2.452-2.273 1.852-8.47z'/%3E %3Cpath stroke='%23FB8648' stroke-linejoin='round' stroke-width='.8' d='M24 28.014l-2.59 1.773.887-3.01-2.487-1.914 3.138-.087 1.051-2.956 1.051 2.956 3.138.087-2.487 1.914.887 3.01z'/%3E %3Ccircle cx='23.999' cy='26.224' r='7.607' stroke='%23FB8648'/%3E %3C/g%3E %3C/g%3E %3C/svg%3E)
'%3E %3Ccircle cx='6.022' cy='6.636' r='5.73' fill='%23FFF' stroke='%2309AEBC'/%3E %3Cpath fill='%2309AEBC' fill-rule='nonzero' d='M4.097 5.328l-.003.181a.321.321 0 0 0-.025.096c.035.515.279.914.726 1.15.34.181.714.295 1.073.44.239.095.491.168.712.295a.456.456 0 0 1 .011.78.832.832 0 0 1-.388.129c-.563.033-1.047-.181-1.474-.535-.074-.06-.131-.087-.2 0-.175.217-.35.435-.53.65-.071.085-.05.152.023.219.407.373.904.63 1.442.746.103.022.13.06.128.159-.005.22 0 .441 0 .663 0 .16.011.173.169.174h.623a.104.104 0 0 0 .09-.03.106.106 0 0 0 .03-.09c0-.246.003-.491 0-.736 0-.082.015-.12.11-.136.346-.057.668-.214.927-.452.368-.336.514-.775.547-1.26.006-.088-.036-.18-.056-.271l-.004-.06a.897.897 0 0 0-.016-.162 1.218 1.218 0 0 0-.658-.779c-.362-.172-.745-.302-1.117-.449-.235-.093-.474-.186-.7-.297a.396.396 0 0 1-.23-.422.399.399 0 0 1 .32-.357c.18-.038.363-.049.545-.03.353.035.664.198.957.392.094.06.151.046.215-.033.154-.196.312-.389.467-.585.127-.16.124-.177-.045-.294-.33-.228-.678-.417-1.077-.5-.19-.039-.188-.046-.188-.236v-.483a.84.84 0 0 0-.028-.14v-.182c.018-.086-.037-.088-.097-.087H5.75c-.114 0-.162.048-.16.162.002.215 0 .431 0 .647 0 .215 0 .219-.205.266-.359.083-.674.242-.917.522-.232.264-.392.566-.37.935z'/%3E %3C/g%3E %3Cpath d='M-4.305-5.5h40v40h-40z'/%3E %3C/g%3E %3C/svg%3E)
